2001•PubMedRequires access

Lipoatrophy associated with glatiramer acetate injections for the treatment of multiple sclerosis.

Linda Y. Hwang, Ida F. Orengo

Abstract

We present a 35-year-old woman with symmetrical lipoatrophy induced by daily glatiramer acetate injections. Glatiramer is indicated as an effective treatment for relapsing-remitting multiple sclerosis (MS) This adverse effect has not been widely reported in the literature; to our knowledge, this is only the seventh reported case of this phenomenon. We suspect that more cases will be identified in the future as glatiramer injections become increasingly prescribed for patients with MS.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 16 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Glatiramer acetate, Medicine, Multiple sclerosis, Lipoatrophy, Adverse effect, Dermatology, Internal medicine, Immunology